EICHORCondition: Healthy Volunteers · Sponsor: The Netherlands Cancer Institute
Interested? Contact the study team ↓
This protocol will be used to collect crucial components of the immune system from healthy volunteers for the characterization of immune cells in fresh blood. A pipeline has been set up for comprehensive immune phenotyping of both lymphoid and myeloid cells within 24 hours after blood withdrawal.
This description comes directly from the study's public registry record.
M Kok, MD · 3120512 · m.kok@nki.nl
L Voorwerk, MD · 3120512 · l.voorwerk@nki.nl
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Age above 35 years * Written informed consent * No history of cancer * No use of systemic immunosuppressive medication (eg. corticosteroids). Local use of corticosteroids (eg. topical or inhalation) is allowed. Exclusion Criteria: * Fever 14 days before blood withdrawal * Donated blood for the same program within the last 2 years * Pregnancy
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| NKI-AVL | Amsterdam, Netherlands | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03819829